JPS6157829B2 - - Google Patents
Info
- Publication number
- JPS6157829B2 JPS6157829B2 JP8362679A JP8362679A JPS6157829B2 JP S6157829 B2 JPS6157829 B2 JP S6157829B2 JP 8362679 A JP8362679 A JP 8362679A JP 8362679 A JP8362679 A JP 8362679A JP S6157829 B2 JPS6157829 B2 JP S6157829B2
- Authority
- JP
- Japan
- Prior art keywords
- sulfonate
- pyridine
- oxide
- chloroform
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- 206010028980 Neoplasm Diseases 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 241001529936 Murinae Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 208000009956 adenocarcinoma Diseases 0.000 description 3
- -1 alkylene dimethane sulfonate Chemical compound 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8362679A JPS567767A (en) | 1979-07-02 | 1979-07-02 | Alkylene di- pyridine-n-oxide-sulfonate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8362679A JPS567767A (en) | 1979-07-02 | 1979-07-02 | Alkylene di- pyridine-n-oxide-sulfonate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS567767A JPS567767A (en) | 1981-01-27 |
| JPS6157829B2 true JPS6157829B2 (enrdf_load_stackoverflow) | 1986-12-09 |
Family
ID=13807675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8362679A Granted JPS567767A (en) | 1979-07-02 | 1979-07-02 | Alkylene di- pyridine-n-oxide-sulfonate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS567767A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6358723U (enrdf_load_stackoverflow) * | 1986-10-03 | 1988-04-19 |
-
1979
- 1979-07-02 JP JP8362679A patent/JPS567767A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6358723U (enrdf_load_stackoverflow) * | 1986-10-03 | 1988-04-19 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS567767A (en) | 1981-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE32518E (en) | Camptothecin derivatives | |
| US6069238A (en) | Spirocyclic C-glycosides | |
| EP0323171A2 (en) | Novel K-252 derivatives having anti-tumor activity and pharmaceutical compositions containing them | |
| EP0799827A1 (en) | Acrylamide derivatives and process for producing the same | |
| EP0159708B1 (en) | Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same | |
| JPS6157829B2 (enrdf_load_stackoverflow) | ||
| EP0000219B1 (en) | Macrocyclic polyether complexes and a process for the isolation of macrocyclic polyethers | |
| EP2149577B1 (en) | New stereospecific method for the preparation of dioxa-bicyclooctane compounds | |
| JP2524804B2 (ja) | 新規なカンプトテシン誘導体及びその製造法 | |
| JPS62145096A (ja) | ２，６−ジデオキシ−２−フルオロ−ｌ−タロピラノ−ス又はその誘導体とその製造法 | |
| WO2004074303A2 (en) | Reagents and methods for preparing lps antagonist b1287 and stereoisomers thereof | |
| EP0284380B1 (en) | Mitomycin derivatives | |
| KR100203729B1 (ko) | 3'-알킬또는아릴실릴옥시벤즈옥사지노리파마이신유도체 | |
| JPS58167592A (ja) | 新規メイタンシノイド化合物 | |
| Szechner et al. | Synthesis and absolute configuration of four diastereoisomeric 1-(2-furyl)-2-aminobutane-1, 3-diols | |
| JP3759772B2 (ja) | アクリルアミド誘導体及びその製造方法 | |
| PL150052B1 (en) | Method of obtaining novel derivatives of androstanocarboxylic-17 beta acid | |
| JPH04225955A (ja) | 置換されたベンズヒドリル２−ヒドロキシプロピルピペラジン誘導体類 | |
| SE438858B (sv) | Halogenerade 15-hydroxi-e-homoeburnanderivat och forfarande for deras framstellning | |
| HU190224B (en) | Process for producing methyl-2-tetradecyl-glycidate | |
| JPH01163175A (ja) | フラン−２−オン誘導体 | |
| EP4363410A1 (en) | Process for the biobased synthesis of schweinfurthins g, k and r | |
| US3732318A (en) | Alpha-chlorosulfoxides and process for preparation thereof | |
| JPS6318590B2 (enrdf_load_stackoverflow) | ||
| JPH04297486A (ja) | 新規アンスラサイクリン系化合物、これを製造するための新規中間体、及びこれを含有する組成物 |